What is Ranomics?
Ranomics is a specialized service provider in cell and protein engineering, catering to the life sciences and biotechnology industries. The company empowers its partners to accelerate research and development through innovative solutions, focusing on custom DNA variant libraries and high-throughput screening. With a proven track record of supporting over 100 projects for leading biotechnology firms and institutions, Ranomics leverages its Ph.D.-level expertise to facilitate breakthroughs in biologic development. The company's current lifecycle stage, indicated by its major enterprise-level funding, suggests a phase of significant scaling and market expansion.
How much funding has Ranomics raised?
Ranomics has raised a total of $2.8M across 2 funding rounds:
Angel/Seed
$1.2M
Angel/Seed
$1.6M
Angel/Seed (2016): $1.2M, investors not publicly disclosed
Angel/Seed (2016): $1.6M, investors not publicly disclosed
What's next for Ranomics?
The substantial enterprise-level funding positions Ranomics for accelerated growth and enhanced service delivery. This capital infusion is expected to fuel further innovation in their cell and protein engineering capabilities, potentially expanding their service offerings and market reach. Strategic investments of this magnitude often signal an intent to scale operations, invest in research and development, and solidify market leadership. Ranomics is poised to continue its trajectory of empowering partners in the life sciences and biotechnology sectors to achieve critical breakthroughs with increased speed and precision.
See full Ranomics company page
